Navigation Links
Life Technologies Launches New Distribution Center in India
Date:7/10/2011

CARLSBAD, Calif. and BANGALORE, India, July 10, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today that it has launched a regional distribution hub in India to address strong customer demand in the South Asia region.

The new India Distribution Center (IDC), located in Bangalore, will boost the availability, timely delivery and quality of Life Technologies' products to its thousands of customers in the area.

"The scientific community in India is growing at a rapid rate," said Devashish Ohri, Managing Director of Life Technologies South Asia. "By locating the India Distribution Center in Bangalore, we can bring our innovative technologies more efficiently to our customers and partners in the region and help advance their science."

"South Asia is one of the fastest growing regions in the world," said Mark Smedley, President of Asia Pacific and Japan for Life Technologies. "Opening the India Distribution Center here is a clear demonstration of Life Technologies' commitment to the scientific community to greatly enhance the timeliness, accuracy and reliability of our product distribution to our Indian customers."

The India Distribution Center, which spans a built-up area of 25,000 square feet, adopts a hub-and-spoke model, with Bangalore as the regional hub for Life Technologies' product distribution throughout India. Since the IDC's inception, Life Technologies' volume of items shipped per day in the region has increased fourfold, with dramatically improved order fulfillment time that is up to 50 percent faster in most cases.

Life Technologies operates as Invitrogen Bioservices India Pvt. Ltd. in India and commenced operations in the year 2005 from Bangalore.  The company recently acquired a part of Labindia, a long time distributor for its Applied Biosystems branded instrument products to become a full service business that offers end-to-end solutions in areas such as research, diagnostics and forensics.

About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition.  Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better.  Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics.  The company manufactures both molecular diagnostic and research use only products.  Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, Gibco, Ambion, Molecular Probes and Taqman products.  Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses.  For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.  Follow Life Technologies on Twitter @LIFECorporation and on Facebook.

Life Technologies' Safe Harbor Statement

This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

Life Technologies Contact:

Vivian Lv
PR & Communications, APAC
+86 10 8446 1901
vivian.lv@lifetech.com


'/>"/>
SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Biobanking: Technologies and Global Markets
2. Stem Cell Technologies: World Market Outlook 2011-2021
3. Wound Management Technologies Webcasting Live from OneMedForum NY Biotech Conference on Thursday, June 23 at 10 am EDT
4. CMHC/MIS Electronic Health Record Solution from Netsmart Technologies Attains Complete ARRA Certification
5. Genetic Technologies Launches BREVAGen™ Breast Cancer Risk Test in US
6. Statement by Ronald L. Stotish, Ph.D., President and CEO of AquaBounty Technologies
7. Life Technologies Launches Highly Efficient Stem Cell Reprogramming Technology
8. Palatin Technologies, Inc. Announces Presentation and Publication on Validation of Scale for Subjective Male Sexual Arousal
9. Merriman Capital Announces Sponsorship of Circadian Technologies on OTCQX
10. Fox Chase Cancer Center Signs Agreement with Life Technologies Corporation
11. Spherix to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... ... Proove Biosciences, Inc. , the commercial and research leader in personalized pain ... partnership is designed to advance research in pain genetics in an effort to bring ... new agreement, researchers at Proove Biosciences are able to collaborate with Luda Diatechnko, MD, ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nutrafol®, a first-to-market smart-supplement for ... and stress related hair loss. With patent-pending formulas for both female hair loss ... in the medical and salon channels nationwide. , Dermatologists, Plastic Surgeons and ...
(Date:5/3/2016)... ... May 03, 2016 , ... Flagship ... Dr. Nancy Gillett to its Board of Directors. Dr. Gillett recently retired from ... Executive Vice President and Chief Scientific Officer. A board-certified veterinary pathologist, Dr. Gillett ...
(Date:5/3/2016)... ... May 03, 2016 , ... According to world renowned prostate cancer surgeon, ... patients traditionally had two main treatment options: surgery or radiation. Based on a patient’s ... New technology has enabled doctors to administer higher doses of radiation to ...
Breaking Biology Technology:
(Date:3/22/2016)... PROVO and SANDY, Utah ... (NSO), which operates the highest sample volume laboratory in ... Tute Genomics and UNIConnect, leaders in clinical sequencing informatics ... the launch of a project to establish the informatics ... NSO has been contracted by the ...
(Date:3/18/2016)... -- --> --> Competitive ... Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & Detection Systems ... security market and the continuing migration crisis in the ... has led visiongain to publish this unique report, which ... defence & security companies in the border security market ...
(Date:3/15/2016)... ALBANY, New York , March 15, 2016 ... a new market report published by Transparency Market Research "Digital ... Growth, Trends and Forecast 2015 - 2023," the global digital ... at US$ 731.9 Mn in 2014 and is forecast to ... to 2023. Growth of micro, small and medium enterprises (MSMEs) ...
Breaking Biology News(10 mins):